Our mission is to improve health through advances in neurotechnology
We introduced the first wearable nerve stimulator for managing chronic pain
We invented the concept of automated nerve testing
We seek to define new product categories and leapfrog existing technology
We are an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
-
Fibromyalgia
Our Quell® Fibromyalgia device is an advanced wearable neuromodulator. It is the first and only FDA authorized medical device that helps reduce the symptoms of fibromyalgia.
-
Peripheral Neuropathy
Our DPNCheck® product provides physicians with a rapid point-of-care test for peripheral neuropathies, which are a common neurological condition associated with diabetes, chemotherapy, autoimmune disorders and other chronic diseases.
-
Entrapment Neuropathy
Our ADVANCE® device helps occupational physicians and orthopedic surgeons evaluate patients with hand and wrist pain, such as due to Carpal Tunnel Syndrome, at the point-of-care.
Due to supply challenges and our evolving business focus, NeuroMetrix will be winding down the ADVANCE nerve conduction testing system over the coming months. We will continue to accept electrode orders until April 30, 2024, and will maintain the report generation system until July 31, 2024.
Over 5 million people worldwide have benefited from NeuroMetrix healthcare products